Literature DB >> 25456878

Comparison of three contemporary surgical scores for predicting all-cause mortality of patients undergoing percutaneous mitral valve repair with the MitraClip system (from the multicenter GRASP-IT registry).

Marianna Adamo1, Davide Capodanno2, Stefano Cannata3, Cristina Giannini4, Maria Luisa Laudisa5, Marco Barbanti3, Salvatore Curello1, Sebastiano Immè3, Diego Maffeo1, Carmelo Grasso3, Francesco Bedogni5, Anna Sonia Petronio4, Federica Ettori1, Corrado Tamburino3.   

Abstract

The aim of this study was to explore the adaptability of 3 contemporary surgical scores (Logistic EuroSCORE [LES], EuroSCORE II [ESII], and Society of Thoracic Surgeons Predicted Risk of Mortality [STS-PROM]) for prediction of mortality after percutaneous mitral valve repair with the MitraClip system. A total of 304 patients from the multicenter Getting Reduction of mitrAl inSufficiency by Percutaneous clip implantation in ITaly registry (GRASP-IT) were stratified based on LES, ESII, and STS-PROM tertiles and analyzed by different measurements of discrimination, calibration, and global accuracy with focus on 30-day and 1-, 2-, and 3-year mortality. A statistically significant gradient in the distribution of mortality was observed at all time points with ESII, at 2 years with LES, and at 2 and 3 years with STS-PROM. ESII had the best discrimination at 30 days (C-statistic 0.80), which remained acceptable at later follow-up, being significantly superior to that of LES at each time point (p = 0.003 at 30 days, p = 0.005 at 1 year, p = 0.011 at 2 years, and p = 0.029 at 3 years). Compared with STS-PROM, ESII showed better discrimination at 30 days (C-statistic 0.80 vs 0.62, p = 0.023). All scores overpredicted the risk of mortality at 30 days and were miscalibrated at 2 and 3 years. At 1 year, there was a good agreement between the observed and predicted probabilities for ESII and STS-PROM, whereas LES remained overpredictive. ESII showed the best global accuracy at 30 days and 1 year, whereas no notable differences were noted versus LES and STS-PROM at 2 and 3 years. In conclusion, lacking specific tools for risk stratification of patients undergoing MitraClip implantation, ESII holds favorable prognostic characteristics, which makes it a valid surrogate.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25456878     DOI: 10.1016/j.amjcard.2014.09.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  MitraClip and Transcatheter Aortic Valve Implantation (TAVI): State of the Art 2015.

Authors:  Alessandro Candreva; Francesco Maisano; Maurizio Taramasso
Journal:  Curr Heart Fail Rep       Date:  2015-12

Review 2.  Mortality after percutaneous edge-to-edge mitral valve repair: a contemporary review.

Authors:  Friso A Kortlandt; Thomas de Beenhouwer; Martin J Swaans; Marco C Post; Jan A S van der Heyden; Frank D Eefting; Benno J W M Rensing
Journal:  Cardiovasc Diagn Ther       Date:  2016-04

3.  The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure.

Authors:  Harun Kundi; Jeffrey J Popma; Linda R Valsdottir; Changyu Shen; Kamil F Faridi; Duane S Pinto; Robert W Yeh
Journal:  Can J Cardiol       Date:  2018-10-13       Impact factor: 5.223

4.  Comparison of percutaneous MitraClip versus mitral valve surgery for severe mitral regurgitation: a meta-analysis: Mitraclip and mitral valve surgery meta-analysis.

Authors:  Tom Kai Ming Wang; Andrew Chatfield; Michael Tzu Min Wang; Peter Ruygrok
Journal:  AsiaIntervention       Date:  2020-12-02

5.  Short-term and 1-year outcomes after MitraClip therapy in functional versus degenerative mitral regurgitation patients: a systematic review and meta-analysis.

Authors:  Xiao-Hang Liu; Jia-Yu Shi; Xiao-Jin Feng; Dong-Cai Feng; Lin Wang; Hai-Yu Pang; Hong-Zhi Xie; Fang-Fei Wang; Jeffrey Hsu; Fu-Wei Jia; Wei Chen
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

6.  The predictive value of conventional surgical risk scores for periprocedural mortality in percutaneous mitral valve repair.

Authors:  F A Kortlandt; C C van 't Klooster; A L M Bakker; M J Swaans; J C Kelder; T L de Kroon; B J W M Rensing; F D Eefting; J A S van der Heyden; M C Post
Journal:  Neth Heart J       Date:  2016-07       Impact factor: 2.380

7.  "Get with the Guidelines Heart Failure Risk Score" for mortality prediction in patients undergoing MitraClip.

Authors:  Christos Iliadis; Maximilian Spieker; Refik Kavsur; Clemens Metze; Martin Hellmich; Patrick Horn; Ralf Westenfeld; Vedat Tiyerili; Marc Ulrich Becher; Malte Kelm; Georg Nickenig; Stephan Baldus; Roman Pfister
Journal:  Clin Res Cardiol       Date:  2021-01-31       Impact factor: 5.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.